407 related articles for article (PubMed ID: 24771510)
81. 2-Methylquinazoline derivative 23BB as a highly selective histone deacetylase 6 inhibitor alleviated cisplatin-induced acute kidney injury.
Hao Y; Guo F; Huang Z; Feng Y; Xia Z; Liu J; Li L; Huang R; Lin L; Ma L; Fu P
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894849
[TBL] [Abstract][Full Text] [Related]
82. Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action.
Abaza MS; Bahman AM; Al-Attiyah RJ; Kollamparambil AM
Tumour Biol; 2012 Dec; 33(6):1951-72. PubMed ID: 23011889
[TBL] [Abstract][Full Text] [Related]
83. NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells.
Miller CP; Ban K; Dujka ME; McConkey DJ; Munsell M; Palladino M; Chandra J
Blood; 2007 Jul; 110(1):267-77. PubMed ID: 17356134
[TBL] [Abstract][Full Text] [Related]
84. Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells.
Catley L; Weisberg E; Kiziltepe T; Tai YT; Hideshima T; Neri P; Tassone P; Atadja P; Chauhan D; Munshi NC; Anderson KC
Blood; 2006 Nov; 108(10):3441-9. PubMed ID: 16728695
[TBL] [Abstract][Full Text] [Related]
85. Histone deacetylase inhibitors: a review on class-I specific inhibition.
Behera J; Jayaprakash V; Sinha BN
Mini Rev Med Chem; 2015; 15(9):731-50. PubMed ID: 25994050
[TBL] [Abstract][Full Text] [Related]
86. Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells.
Kawabata S; Gills JJ; Mercado-Matos JR; Lopiccolo J; Wilson W; Hollander MC; Dennis PA
Cell Death Dis; 2012 Jul; 3(7):e353. PubMed ID: 22825471
[TBL] [Abstract][Full Text] [Related]
87. Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine.
Cosenza M; Civallero M; Marcheselli L; Sacchi S; Pozzi S
Apoptosis; 2017 Jun; 22(6):827-840. PubMed ID: 28315173
[TBL] [Abstract][Full Text] [Related]
88. Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation.
Hillert EK; Brnjic S; Zhang X; Mazurkiewicz M; Saei AA; Mofers A; Selvaraju K; Zubarev R; Linder S; D'Arcy P
Cancer Lett; 2019 Apr; 448():70-83. PubMed ID: 30768956
[TBL] [Abstract][Full Text] [Related]
89. A new curcumin analogue exhibits enhanced antitumor activity in nasopharyngeal carcinoma.
Pan Y; Xiao J; Liang G; Wang M; Wang D; Wang S; Yang H
Oncol Rep; 2013 Jul; 30(1):239-45. PubMed ID: 23673810
[TBL] [Abstract][Full Text] [Related]
90. Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma.
Hideshima T; Qi J; Paranal RM; Tang W; Greenberg E; West N; Colling ME; Estiu G; Mazitschek R; Perry JA; Ohguchi H; Cottini F; Mimura N; Görgün G; Tai YT; Richardson PG; Carrasco RD; Wiest O; Schreiber SL; Anderson KC; Bradner JE
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13162-13167. PubMed ID: 27799547
[TBL] [Abstract][Full Text] [Related]
91. Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis.
Kraus M; Malenke E; Gogel J; Müller H; Rückrich T; Overkleeft H; Ovaa H; Koscielniak E; Hartmann JT; Driessen C
Mol Cancer Ther; 2008 Jul; 7(7):1940-8. PubMed ID: 18645004
[TBL] [Abstract][Full Text] [Related]
92. Discovery of class I histone deacetylase inhibitors based on romidpesin with promising selectivity for cancer cells.
Zhang K; Yao Y; Tu Z; Liao C; Wang Z; Qiu Y; Chen D; Hamilton DJ; Li Z; Jiang S
Future Med Chem; 2020 Feb; 12(4):311-323. PubMed ID: 31782319
[No Abstract] [Full Text] [Related]
93. A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors.
New M; Olzscha H; Liu G; Khan O; Stimson L; McGouran J; Kerr D; Coutts A; Kessler B; Middleton M; La Thangue NB
Cell Death Differ; 2013 Oct; 20(10):1306-16. PubMed ID: 23703321
[TBL] [Abstract][Full Text] [Related]
94. Inhibitors of histone deacetylase as new anticancer agents.
Jung M
Curr Med Chem; 2001 Oct; 8(12):1505-11. PubMed ID: 11562279
[TBL] [Abstract][Full Text] [Related]
95. Mechanistic Study of Tetrahydrofuran- acetogenins In Triggering Endoplasmic Reticulum Stress Response-apotoposis in Human Nasopharyngeal Carcinoma.
Juang SH; Chiang CY; Liang FP; Chan HH; Yang JS; Wang SH; Lin YC; Kuo PC; Shen MR; Thang TD; Nguyet BT; Kuo SC; Wu TS
Sci Rep; 2016 Dec; 6():39251. PubMed ID: 28000792
[TBL] [Abstract][Full Text] [Related]
96. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.
Golden EB; Lam PY; Kardosh A; Gaffney KJ; Cadenas E; Louie SG; Petasis NA; Chen TC; Schönthal AH
Blood; 2009 Jun; 113(23):5927-37. PubMed ID: 19190249
[TBL] [Abstract][Full Text] [Related]
97. Combined inhibition of autophagy and Nrf2 signaling augments bortezomib-induced apoptosis by increasing ROS production and ER stress in pancreatic cancer cells.
Li X; Liang M; Jiang J; He R; Wang M; Guo X; Shen M; Qin R
Int J Biol Sci; 2018; 14(10):1291-1305. PubMed ID: 30123077
[TBL] [Abstract][Full Text] [Related]
98. The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21.
Son DS; Wilson AJ; Parl AK; Khabele D
Cancer Biol Ther; 2010 Jun; 9(11):928-35. PubMed ID: 20404564
[TBL] [Abstract][Full Text] [Related]
99. The aggresome pathway as a target for therapy in hematologic malignancies.
Simms-Waldrip T; Rodriguez-Gonzalez A; Lin T; Ikeda AK; Fu C; Sakamoto KM
Mol Genet Metab; 2008 Jul; 94(3):283-6. PubMed ID: 18472289
[TBL] [Abstract][Full Text] [Related]
100. Calcium channel blocker verapamil accelerates gambogic acid-induced cytotoxicity via enhancing proteasome inhibition and ROS generation.
Liu N; Huang H; Liu S; Li X; Yang C; Dou QP; Liu J
Toxicol In Vitro; 2014 Apr; 28(3):419-25. PubMed ID: 24373880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
